However, ECs in tumor vessels did not exhibit an altered Cav1 expression during prostate cancer progression: a high expression of Cav1 was detected in the tumor vasculature in all tissue samples analyzed independently from the Gleason score (Figure 5 arrows). This evidence concerns the gene CAV1 and Familial prostate cancer.